Abstract
Purchase PDF (141 K)
E-mail Article
Add to my Quick Links
Cited By in Scopus (1)
Purchase PDF (794 K)
doi:10.1016/j.brainresbull.2006.10.030 
Copyright © 2006 Elsevier Inc. All rights reserved.
Testing the possible inhibition of proteasome by direct interaction with ubiquitylated and aggregated huntingtin
Available online 20 November 2006.
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Abstract
An impairment of the ubiquitin–proteasome system (UPS) has been postulated in Huntington's disease (HD) and in other CAG-triplet repeat disorders. This hypothesis arises from the observation that polyglutamine (polyQ)-containing inclusion bodies that are characteristic of these diseases also contain components of the UPS. However, since that initial discovery, the UPS impairment hypothesis has remained controversial. Recent in vitro enzymatic studies revealed the inability of eukaryotic proteasomes to digest expanded polyQ, thus suggesting that occasional failure of polyQ to exit the proteasome may interfere with its proteolytic function. However, it has also recently been found that in vitro assembled aggregates made of synthetic polyQ fail to inhibit proteasome activity. Here we propose future experiments that may help to ellucidate whether a direct interaction between proteasomes and polyQ stretches or aggregates can result in inhibition of proteasome activity.
Keywords: Huntington's disease; Proteasome activity; Inclusion bodies; Filaments
